The notion in the current study that synbiotics have downregulated IL-6, STAT3, COX-2, and TNF-α genes, which are normally associated with inflammation and tumorigenesis in colon epithelium could possibly disclose new promising therapeutic avenue for patients with colitis-associated colorectal cancer. This evidence concerns the gene STAT3 and colitis.